Lincomycin labels and packages: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Lincomycin}} {{CMG}}; {{AE}} {{AK}} [image:Pfizer.jpg]] '''PRINCIPAL DISPLAY PANEL - 1-2 mL Vial Label Pfizer''' NDC 0009-0555-01 Lincocin® lincomycin injec...")
 
No edit summary
 
Line 43: Line 43:


{|
{|
| [[image:Lincocin2.jpg]]
| [[image:Lincocin2.jpg|400px|thumb]]
|}
|}



Latest revision as of 20:41, 9 January 2014

Lincomycin
LINCOCIN®, LINCOMED®, LINCOMIX® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings
Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Compatiblity
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

[image:Pfizer.jpg]]

PRINCIPAL DISPLAY PANEL - 1-2 mL Vial Label

Pfizer

NDC 0009-0555-01

Lincocin® lincomycin injection, USP

300 mg/mL

1-2 mL Vial Rx only

PRINCIPAL DISPLAY PANEL - 1-2 mL Vial Carton

Pfizer NDC 0009-0555-01

Lincocin® lincomycin injection, USP

300 mg/mL*

For intramuscular or intravenous use

1-2 mL Vial Rx only

References

http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050317s172lbl.pdf